main image

Collaborative Projects & Research

Nanosyn is entirely devoted to satisfying its clients by delivering what they want when they want it. Whatever your needs are: hit optimization, lead expansion, medicinal chemistry, etc. Nanosyn's skilled scientific team is ready to work with you to meet each and every one of your needs.

Here are some of the reasons why our clients choose to collaborate with Nanosyn:

  • Intellectual property (IP) protection
  • Fast turn-around time
  • Personal commitment to deliver 100% on time
  • High quality and efficiency in every respect
  • Convenient exchange of information and data
  • Open strategic discussions (Design, BB Panel, Synthesis, etc.)
  • Competitive FTE base pricing
  • Weekly teleconferences, WebEx
  • Weekly progress reports and updates
  • Scheduled onsite meetings

 For more information about our Collaborative Projects & Contract Research services please contact us.

Partnership in Drug Discovery

Previous and On-Going Collaborations

May 30, 2017 - NeurAegis has chosen Nanosyn to lead its chemistry efforts towards advancing novel and selective calpain-2 inhibitors to clinical candidates

February 8, 2017 - Nanosyn announces a continuation of collaboration in the Epigenetic Research Initiative with the Mayo Clinic

April 14, 2015 - Nanosyn and The Leukemia & Lymphoma Society Announce Achieving a Significant Milestone in Developing New Therapies for MLL Leukemia

July 21, 2014 - Nanosyn announces expanded partnership with Forma Therapeutics

August 12, 2009 - Nanosyn, Inc. and PCAS announce the signing of a joint-venture to operate PCAS-Nanosyn

Publications & Presentations

October 26, 2015 - Nanosyn and Collaborators Publish Research on PKIS in Issue of Nature Biotechnology

March 20, 2012 - 2nd RSC Symposium on Chemical Biology for Drug Discovery - GlaxoSmithKline


Nanosyn on Facebook Nanosyn on Twitter Nanosyn on LinkedIn